Long survival in a patient with fumarate hydratase mutation-associated glioma
J Neuropathol Exp Neurol
.
2024 Sep 16:nlae100.
doi: 10.1093/jnen/nlae100.
Online ahead of print.
Authors
Regina R Reimann
1
,
Dorothee Gramatzki
2
,
Andrea Bink
3
,
Jürgen Hench
4
,
Stephan Frank
4
,
Martina Haberecker
5
,
Tibor Hortobagyi
1
,
Kristof Egervari
6
,
Doron Merkler
6
,
Kenneth Aldape
7
,
Michael Weller
2
Affiliations
1
Institute of Neuropathology, University Hospital and University of Zurich, Zurich, Switzerland.
2
Department of Neurology, University Hospital and University of Zurich, Zurich, Switzerland.
3
Department of Neuroradiology, University Hospital Zurich, Zurich, Switzerland.
4
Division of Neuropathology, Institute for Pathology, University Hospital Basel, Basel, Switzerland.
5
Institute of Pathology and Molecular Pathology, University Hospital Zurich, Zurich, Switzerland.
6
Division of Clinical Pathology, Geneva University Hospital, Geneva, Switzerland.
7
Laboratory of Pathology, Center for Cancer Research, National Cancer Institute, Bethesda, MD, United States.
PMID:
39279228
DOI:
10.1093/jnen/nlae100
No abstract available